Shandong Weigao Group Medical Polymer Company Limited (1066.HK)
1066.HK Stock Price Chart
Explore Shandong Weigao Group Medical Polymer Company Limited interactive price chart. Choose custom timeframes to analyze 1066.HK price movements and trends.
1066.HK Company Profile
Discover essential business fundamentals and corporate details for Shandong Weigao Group Medical Polymer Company Limited (1066.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
27 Feb 2004
Employees
12.72K
Website
https://www.weigaogroup.comCEO
Rinan Cong
Description
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
1066.HK Financial Timeline
Browse a chronological timeline of Shandong Weigao Group Medical Polymer Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Mar 2026
Upcoming earnings on 24 Mar 2026
Dividend declared on 20 Oct 2025
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend will be paid on 21 Nov 2025.
Earnings released on 27 Aug 2025
EPS came in at $0.24 falling short of the estimated $0.28 by -15.37%, while revenue for the quarter reached $7.28B , missing expectations by -4.19%.
Dividend declared on 2 Jun 2025
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 11 Jul 2025.
Earnings released on 28 May 2025
Earnings released on 26 Mar 2025
EPS came in at $0.12 falling short of the estimated $0.24 by -52.57%, while revenue for the quarter reached $3.57B , missing expectations by -51.59%.
Earnings released on 31 Dec 2024
EPS came in at $0.11 , while revenue for the quarter reached $3.43B .
Dividend declared on 18 Oct 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 22 Nov 2024.
Earnings released on 28 Aug 2024
EPS came in at $0.13 falling short of the estimated $0.26 by -50.02%, while revenue for the quarter reached $3.56B , missing expectations by -51.48%.
Dividend declared on 3 Jun 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 12 Jul 2024.
Earnings released on 28 May 2024
EPS came in at $0.13 , while revenue for the quarter reached $3.59B .
Earnings released on 28 Mar 2024
EPS came in at $0.10 , while revenue for the quarter reached $3.50B , missing expectations by -77.98%.
Earnings released on 26 Mar 2024
EPS came in at $0.10 falling short of the estimated $0.19 by -49.09%, while revenue for the quarter reached $3.40B , missing expectations by -78.24%.
Dividend declared on 19 Oct 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 24 Nov 2023.
Earnings released on 29 Aug 2023
EPS came in at $0.14 falling short of the estimated $0.29 by -50.75%, while revenue for the quarter reached $3.73B , missing expectations by -52.10%.
Dividend declared on 1 Jun 2023
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 14 Jul 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.15 , while revenue for the quarter reached $3.94B .
Earnings released on 30 Mar 2023
EPS came in at $0.16 falling short of the estimated $0.31 by -49.15%, while revenue for the quarter reached $3.80B , missing expectations by -79.08%.
Dividend declared on 3 Oct 2022
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 11 Nov 2022.
Earnings released on 30 Sept 2022
EPS came in at $0.15 , while revenue for the quarter reached $3.66B .
Earnings released on 22 Aug 2022
EPS came in at $0.21 falling short of the estimated $0.33 by -36.46%, while revenue for the quarter reached $4.36B , missing expectations by -45.33%.
Earnings released on 30 Jun 2022
EPS came in at $0.20 , while revenue for the quarter reached $4.14B .
Dividend declared on 9 Jun 2022
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 15 Jul 2022.
Earnings released on 29 Mar 2022
EPS came in at $0.14 falling short of the estimated $0.38 by -62.16%, while revenue for the quarter reached $4.27B , missing expectations by -52.05%.
Earnings released on 23 Feb 2022
EPS came in at $0.14 , while revenue for the quarter reached $4.21B .
Dividend declared on 29 Sept 2021
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 5 Nov 2021.
Earnings released on 27 Aug 2021
EPS came in at $0.16 falling short of the estimated $0.32 by -50.26%, while revenue for the quarter reached $3.74B , missing expectations by -50.63%.
Dividend declared on 27 May 2021
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 5 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.16 , while revenue for the quarter reached $3.69B .
Earnings released on 30 Mar 2021
EPS came in at $0.14 falling short of the estimated $0.36 by -59.60%, while revenue for the quarter reached $3.80B , missing expectations by -50.39%.
Dividend declared on 16 Oct 2020
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 20 Nov 2020.
Earnings released on 30 Sept 2020
EPS came in at $0.14 , while revenue for the quarter reached $3.65B .
1066.HK Stock Performance
Access detailed 1066.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.